IRCT20180711040431N1招募中3 期
Evaluation of efficacy and safety of dabigatran(paradxa) in pediatric thromboembolism: a pilot study
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 1 year 至 18 years（—）
- 性别
- All
入选标准
- •Informed consent
- •Children under 18 years
- •Affected by Thromboembolism
排除标准
- •Having other blood disorders
研究者
相似试验
Unknown
不适用
Real-World Effectiveness and Safety of Dabigatran in Geriatric Patients with Atrial FibrillatioDabigatran was used to prevent ischemic stroke in atrial fibrillation but effectiveness and safety are diferent between geriatric patients and young patients.dabigatran, non-vitamin k antagonist oral anticoagulants, NOAC, direct oral anticoagulant, DOAC, geriatric, elderly, atrial fibrillation, ischemic stroke, bleedingTCTR20221222001Faculty of Pharmacy, Silpakorn University2,134
招募中
不适用
Evaluation of efficacy and safety of Dabigaran in patients with catheter ablation for atrial fibrillation.Atrial fibrillationJPRN-UMIN000011223Osaka City University Graduate School of Medicine140
招募中
不适用
Effect of Dabigatran (drug) in liver cirrhosis (liver disease)CTRI/2020/06/025846Institute of Liver and Biliary Sciences
已完成
不适用
The Comparative Safety and Effectiveness of Dabigatran, Versus Rivaroxaban, and Apixaban Utilized in the Department of Defense Non-Valvular Atrial Fibrillation Patient Population: A Retrospective Database AnalysisAtrial FibrillationNCT03026556Boehringer Ingelheim42,534
进行中（未招募）
1 期
ew medication for the prophylaxis of thrombosis in patients with mechanical heart supportpatients with implanted left ventricular assist deviceMedDRA version: 13.1Level: LLTClassification code 10052374Term: Left ventricular assist device insertionSystem Organ Class: 10042613 - Surgical and medical proceduresEUCTR2010-024534-38-ATMedizinische Universität Wien, Abteilung für Herzchirurgie30